carbachol has been researched along with Coronary Disease in 10 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (50.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ginsburg, R | 1 |
| Bristow, MR | 1 |
| Davis, K | 1 |
| Dibiase, A | 1 |
| Billingham, ME | 1 |
| Cockcroft, JR | 1 |
| Chowienczyk, PJ | 1 |
| Ritter, JM | 1 |
| Ritchie, AJ | 1 |
| Hartshorn, S | 1 |
| Crosbie, AE | 1 |
| Callingham, BA | 1 |
| Latimer, RD | 1 |
| Vuylsteke, A | 1 |
| Eschenhagen, T | 1 |
| Mende, U | 1 |
| Nose, M | 1 |
| Schmitz, W | 1 |
| Scholz, H | 1 |
| Schulte am Esch, J | 1 |
| Sempell, R | 1 |
| Warnholtz, A | 1 |
| Wüstel, JM | 1 |
| Niroomand, F | 1 |
| Bangert, M | 1 |
| Beyer, T | 1 |
| Rauch, B | 1 |
| Böhm, M | 1 |
| Gierschik, P | 1 |
| Jakobs, KH | 1 |
| Pieske, B | 1 |
| Schnabel, P | 1 |
| Ungerer, M | 1 |
| Erdmann, E | 1 |
| Wu, Y | 1 |
| Chen, GX | 1 |
| Hsu, HC | 1 |
| Kim, EA | 1 |
| Danilenko, MP | 1 |
| Esyrev, OV | 1 |
| Hiatt, RL | 1 |
| Deutsch, AR | 1 |
| Ringer, C | 1 |
| Oreshuk, FA | 1 |
| Shifrin, EG | 1 |
| Protasevich, AA | 1 |
10 other studies available for carbachol and Coronary Disease
| Article | Year |
|---|---|
Quantitative pharmacologic responses of normal and atherosclerotic isolated human epicardial coronary arteries.
Topics: Calcium; Carbachol; Coronary Disease; Coronary Vessels; Ergonovine; Histamine; Humans; In Vitro Tech | 1984 |
Hyperlipidaemia, hypertension; and coronary heart disease.
Topics: Acetylcholine; Carbachol; Cholesterol; Coronary Disease; Endothelium, Vascular; Forearm; Humans; Hyp | 1995 |
The action of diaspirin cross-linked haemoglobin blood substitute on human arterial bypass conduits.
Topics: Aged; Aspirin; Blood Substitutes; Carbachol; Cholinergic Agents; Coronary Artery Bypass; Coronary Di | 2000 |
Regulation and possible functional implications of G-protein mRNA expression in nonfailing and failing ventricular myocardium.
Topics: Adult; Animals; Carbachol; Cardiomyopathy, Dilated; Coronary Disease; Female; Gene Expression Regula | 1992 |
Reduced adenylyl cyclase inhibition by carbachol and GTP during acute myocardial ischaemia.
Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Animals; Carbachol; Colforsin; Coronary Disease; Dog | 1992 |
Increase of Gi alpha in human hearts with dilated but not ischemic cardiomyopathy.
Topics: Adenosine Diphosphate Ribose; Adenylate Cyclase Toxin; Adenylyl Cyclases; Adult; Carbachol; Cardiomy | 1990 |
[Effects of carbamylcholine on the ventricular fibrillation threshold and its relation to the levels of cAMP and cGMP in rat ischemic ventricle].
Topics: Animals; Carbachol; Coronary Disease; Cyclic AMP; Cyclic GMP; Epinephrine; Female; In Vitro Techniqu | 1985 |
[Changes in the activity and regulatory properties of Na, K-ATPase from the myocardial sarcolemma in total graded ischemia].
Topics: Animals; Atropine; Carbachol; Coronary Disease; Digoxin; Dose-Response Relationship, Drug; Guinea Pi | 1987 |
Low tension glaucoma.
Topics: Aged; Bronchitis; Carbachol; Cardiovascular Diseases; Coronary Disease; Diabetes Complications; Fema | 1971 |
[Action of several pharmacological substances on the collateral circulation of the myocardium during the shunting of its blood supply].
Topics: Animals; Arteries; Blood Pressure; Carbachol; Carotid Arteries; Collateral Circulation; Coronary Dis | 1969 |